Literature DB >> 9029153

Cdk2-dependent phosphorylation of Id2 modulates activity of E2A-related transcription factors.

E Hara1, M Hall, G Peters.   

Abstract

The helix-loop-helix (HLH) protein Id2 is thought to affect the balance between cell growth and differentiation by negatively regulating the function of basic-helix-loop-helix (bHLH) transcription factors. Id2 acts by forming heterodimers that are unable to bind to specific (E-box) DNA sequences. Here we show that this activity can be overcome by phosphorylation of a serine residue within a consensus target site for cyclin-dependent kinases (Cdks). In vitro, Id2 can be phosphorylated by either cyclin E-Cdk2 or cyclin A-Cdk2 but not by cyclin D-dependent kinases. Analogous phosphorylation occurs in serum-stimulated human diploid fibroblasts at a time in late G1 consistent with the appearance of active cyclin E-Cdk2. The phosphorylation of Id2 in these cells correlates with the restoration of a distinct E-box-dependent DNA-binding complex, suggesting that the levels of this complex are modulated by both the abundance and phosphorylation status of Id2. These data provide a link between cyclin-dependent kinases and bHLH transcription factors that may be critical for the regulation of cell proliferation and differentiation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9029153      PMCID: PMC1169639          DOI: 10.1093/emboj/16.2.332

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  49 in total

1.  XIdx, a dominant negative regulator of bHLH function in early Xenopus embryos.

Authors:  R Wilson; T Mohun
Journal:  Mech Dev       Date:  1995-02       Impact factor: 1.882

Review 2.  DP and E2F proteins: coordinating transcription with cell cycle progression.

Authors:  E W Lam; N B La Thangue
Journal:  Curr Opin Cell Biol       Date:  1994-12       Impact factor: 8.382

Review 3.  G1 phase progression: cycling on cue.

Authors:  C J Sherr
Journal:  Cell       Date:  1994-11-18       Impact factor: 41.582

4.  B lineage--specific interactions of an immunoglobulin enhancer with cellular factors in vivo.

Authors:  A Ephrussi; G M Church; S Tonegawa; W Gilbert
Journal:  Science       Date:  1985-01-11       Impact factor: 47.728

5.  A new human diploid cell strain, TIG-1, for the research on cellular aging.

Authors:  M Ohashi; S Aizawa; H Ooka; T Ohsawa; K Kaji; H Kondo; T Kobayashi; T Noumura; M Matsuo; Y Mitsui; S Murota; K Yamamoto; H Ito; H Shimada; T Utakoji
Journal:  Exp Gerontol       Date:  1980       Impact factor: 4.032

6.  Collaboration of G1 cyclins in the functional inactivation of the retinoblastoma protein.

Authors:  M Hatakeyama; J A Brill; G R Fink; R A Weinberg
Journal:  Genes Dev       Date:  1994-08-01       Impact factor: 11.361

Review 7.  The D-type cyclins and their role in tumorigenesis.

Authors:  G Peters
Journal:  J Cell Sci Suppl       Date:  1994

8.  Constitutive expression of the Id1 gene impairs mouse B cell development.

Authors:  X H Sun
Journal:  Cell       Date:  1994-12-02       Impact factor: 41.582

9.  Phosphorylation of helix-loop-helix proteins ID1, ID2 and ID3.

Authors:  Y Nagata; W Shoji; M Obinata; K Todokoro
Journal:  Biochem Biophys Res Commun       Date:  1995-02-27       Impact factor: 3.575

10.  Lack of cyclin D-Cdk complexes in Rb-negative cells correlates with high levels of p16INK4/MTS1 tumour suppressor gene product.

Authors:  D Parry; S Bates; D J Mann; G Peters
Journal:  EMBO J       Date:  1995-02-01       Impact factor: 11.598

View more
  37 in total

1.  Id helix-loop-helix proteins antagonize pax transcription factor activity by inhibiting DNA binding.

Authors:  E C Roberts; R W Deed; T Inoue; J D Norton; A D Sharrocks
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

2.  Impaired immune responses and B-cell proliferation in mice lacking the Id3 gene.

Authors:  L Pan; S Sato; J P Frederick; X H Sun; Y Zhuang
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

Review 3.  Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms.

Authors:  M E Massari; C Murre
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

4.  Evidence that helix-loop-helix proteins collaborate with retinoblastoma tumor suppressor protein to regulate cortical neurogenesis.

Authors:  J G Toma; H El-Bizri; F Barnabe-Heider; R Aloyz; F D Miller
Journal:  J Neurosci       Date:  2000-10-15       Impact factor: 6.167

Review 5.  Helix-loop-helix proteins in mammary gland development and breast cancer.

Authors:  Pierre-Yves Desprez; Tomoki Sumida; Jean-Philippe Coppé
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-04       Impact factor: 2.673

6.  Inhibition of HTLV-1 transcription by cyclin dependent kinase inhibitors.

Authors:  Lai Wang; Longwen Deng; Kaili Wu; Cynthia de la Fuente; Dai Wang; Kylene Kehn; Anil Maddukuri; Shanese Baylor; Francisco Santiago; Emmanuel Agbottah; Sylviane Trigon; Michel Morange; Renaud Mahieux; Fatah Kashanchi
Journal:  Mol Cell Biochem       Date:  2002-08       Impact factor: 3.396

7.  Cyclin E associates with components of the pre-mRNA splicing machinery in mammalian cells.

Authors:  W Seghezzi; K Chua; F Shanahan; O Gozani; R Reed; E Lees
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

8.  Suppression of adenovirus E1A-induced apoptosis by mutated p53 is overcome by coexpression with Id proteins.

Authors:  T Nakajima; M Yageta; K Shiotsu; K Morita; M Suzuki; Y Tomooka; K Oda
Journal:  Proc Natl Acad Sci U S A       Date:  1998-09-01       Impact factor: 11.205

9.  Id2 promotes apoptosis by a novel mechanism independent of dimerization to basic helix-loop-helix factors.

Authors:  M Florio; M C Hernandez; H Yang; H K Shu; J L Cleveland; M A Israel
Journal:  Mol Cell Biol       Date:  1998-09       Impact factor: 4.272

Review 10.  Transcriptional control of the cell cycle in mammary gland development and tumorigenesis.

Authors:  Ricardo D Coletta; Paul Jedlicka; Arthur Gutierrez-Hartmann; Heide L Ford
Journal:  J Mammary Gland Biol Neoplasia       Date:  2004-01       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.